Pediatrix Medical Group, Inc. (MD)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,734 | 1,911 | 1,972 | 1,995 | 2,013 | 1,914 | 1,951 | 1,961 |
| Operating profit | $m | 231 | 226 | ||||||
| Net profit | $m | -796 | 131 | 66 | -60 | -99 | 165 | 175 | 201 |
| EPS reported | $ | 1.94 | 2.09 | ||||||
| Operating cashflow per share | $ | 3.18 | 3.11 | ||||||
| Capex per share | $ | 0.22 | 0.23 | ||||||
| FCF per share | $ | 2.96 | 2.88 | ||||||
| Free cash flow | $m | 253 | 229 | ||||||
| Net debt | $m | 133 | 180 | ||||||
| Book value equity | $m | 866 | 881 | ||||||
| Book value per share | $ | 10.15 | 10.82 | ||||||
| Number of shares | m | 85.27 | 81.41 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 11.03 | 12.59 | ||||||
| P/B LTM | x | 2.11 | 2.07 | ||||||
| P/S LTM | x | 0.95 | 0.94 | ||||||
| P/FCF LTM | x | 7.22 | 7.97 | ||||||
| EV/EBITDA LTM | x | 7.69 | 7.90 | ||||||
| EV/Sales LTM | x | 1.10 | 1.29 | ||||||
| Earnings Yield LTM | % | +9.07% | +7.94% | ||||||
| FCF Yield | % | +13.85% | +12.55% | ||||||
| Quality | |||||||||
| ROE | % | +19.10% | +19.89% | ||||||
| ROIC | % | +9.67% | +9.57% | ||||||
| Operating margin | % | +12.07% | +11.60% | ||||||
| Gross margin | % | +24.66% | +25.95% | ||||||
| FCF/Sales | % | +13.20% | +11.74% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -4.92% | -3.09% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +36.89% | +24.06% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.38 | 0.37 | ||||||
| Net Debt/EBITDA | x | 1.04 | 1.24 | ||||||
| EBIT/Net interest | x | 6.43 | 8.01 | ||||||
| Net debt/market cap | % | +34.71% | +26.74% | ||||||
| Net debt/Equity | x | 0.15 | 0.20 | ||||||
| Gross debt/equity | x | 0.76 | 0.70 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free